Relationship of P-glycoprotein (Pgp) Expression and Estrogen Receptor (ER) Expression in Invasive Ductal Carcinoma of Breast Cancer
Keywords:
Immunohistochemistry, ER, P-gp, invasive ductal carcinoma, breast cancer.Abstract
Increased of estrogen receptor (ER) expression resulting in activation of downstream signaling pathways including cAMP/PKA, MAPK/ERK and PI3K/AKT. The Association of estrogen receptor expression and P-glycoprotein 1 (P-gp) expression is not clear yet. The aims of this study is to explore the influence of signaling cascades of estrogen receptors
References
Taheri, M. and F. Mahjoubi, MRP1 but not MDR1 is associated with response to neoadjuvant chemotherapy in breast cancer patients. Dis Markers, 2013. 34(6): p. 387-93.
Fan, W. and M. Sui, Roles and Mechanisms of Estrogen and Estrogen Receptors in Breast Cancer Resistant to Chemotherapy. 2011.
Martin, H.L., Smith, L. & Tomlinson, D. , Multidrug-resistant breast cancer: current perspectives. 2014. .
Zampieri, L., et al., Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells. Anticancer research, 2001. 22(4): p. 2253-2259.
Mutoh, K., et al., Estrogen?mediated post transcriptional down?regulation of P?glycoprotein in MDR1?transduced human breast cancer cells. Cancer science, 2006. 97(11): p. 1198-1204.
Hamidovic, A., Hahn, K. & Kolesar, J. , Clinical significance of ABCB1 genotyping in oncology. Journal of Oncology Pharmacy Practice, , 2010. . 16, : p. 39-44.
Fan, W.S., M. , Roles and Mechanisms of Estrogen and Estrogen Receptors in Breast Cancer Resistant to Chemotherapy. 2011. .
Fairchild, C.R., et al., Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer research, 1987. 47(19): p. 5141-5148.
Singh, J.P., et al., Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer-a prospective clinical study. World journal of surgical oncology, 2005. 3(1): p. 61.
Gottesman, M.M., T. Fojo, and S.E. Bates, Multidrug resistance in cancer: role of ATP
Singh, J.P., Mittal, M. K., Saxena, S., Bansal, A., Bhatia, A. & Kulshreshtha, P. , Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer-a prospective clinical study. . World journal of surgical oncology, , 2005. . 3,: p. 61.
Chevillard, S., et al., Sequential assessment of multidrug resistance phenotype and measurement of S?phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer, 1996. 77(2): p. 292-300.
Chung, H.C., et al., P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer. Breast cancer research and treatment, 1997. 42(1): p. 65-72.
Shi, J.F., et al., ERalpha directly activated the MDR1 transcription to increase paclitaxel-resistance of ERalpha-positive breast cancer cells in vitro and in vivo. Int J Biochem Cell Biol, 2014. 53: p. 35-45.
Mutoh, K., Tsukahara, S., Mitsuhashi, J., Katayama, K. & Sugimoto, Y. , Estrogen?mediated post transcriptional down?regulation of P?glycoprotein in MDR1?transduced human breast cancer cells. . Cancer science, , 2006. . 97, : p. 1198-1204.
Chen, Q., Y. Bian, and S. Zeng, Involvement of AP-1 and NF-?B in the Up-regulation of P-gp in Vinblastine Resistant Caco-2 Cells. Drug metabolism and pharmacokinetics, 2013.
Martin, H.L., L. Smith, and D. Tomlinson, Multidrug-resistant breast cancer: current perspectives. 2014.
Tomiyasu, H., et al., Regulation of expression of ABCB1 and LRP genes by mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and its role in generation of side population cells in canine lymphoma cell lines. Leukemia & lymphoma, 2013. 54(6): p. 1309-1315.
kYang JM, V.A., Hait WN, Activation of phospholipase C induces Raf-MAPK pathway. . Mol Pharmacol 2001 60: p. 674-680.
Katayama, K., et al., Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein. Molecular cancer therapeutics, 2007. 6(7): p. 2092-2102.
Lage, H., Drug resistance in breast cancer. Cancer Therapy, 2003. 1: p. 81-91.
Zhang, Z., et al., Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools? Journal of thoracic disease, 2014. 6(6): p. 785.
Tanei, T., et al., Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer. European Journal of Surgical Oncology (EJSO), 2011. 37(2): p. 155-161.
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.